Efficiency of antitumor screening relative to activity criteriaPAULL, K; HODES, L; SIMON, R. M et al.Journal of the National Cancer Institute. 1986, Vol 76, Num 6, pp 1137-1142, issn 0027-8874Article

Comparison of in vitro assays for detecting subpopulations of P388 leukemic cells resistant to AraC = Comparaison de tests in vitro pour déceler les sous-populations de cellules leucémiques P388 résistantes à l'araCRAZA, A; KULICZKOWSKI, K; WEIDONG, G et al.Medical oncology and tumor pharmacotherapy. 1984, Vol 1, Num 3, pp 163-168, issn 0736-0118Article

Characterization of the activity of α/β-triglycidylurazol (TGU; NSC-332488): a new antineoplastic compoundATASSI, G; DUMONT, P; VANHAELEN, C et al.European journal of cancer & clinical oncology. 1984, Vol 20, Num 9, pp 1187-1191, issn 0277-5379Article

Reversal of multidrug resistance by non-antitumor anthracycline analogsINABA, M; NAGASHIMA, K; SAKURAI, Y et al.Japanese journal of cancer research. 1984, Vol 75, Num 12, pp 1049-1052, issn 0910-5050Article

Vincristine-resistant P388 leukemia cells contain a large amount of calcium = Les cellules de leucémie P388 résistantes à la vincristine contiennent une grande quantité de calciumTSURUO, T; IIDA, H; TSUKAGOSHI, S et al.Gann. 1983, Vol 74, Num 5, pp 619-621, issn 0016-450XArticle

Synthesis of 2H-pyran-2-one derivatives from matricaria esterPROKSA, B; UHRIN, D; FUSKA, J et al.Pharmazie. 1986, Vol 41, Num 10, pp 703-704, issn 0031-7144Article

Proposed structure of the cyclic peptide dolastatin 3, a powerful cell growth inhibitor, should be revisedHAMADA, Y; KOHDA, K; SHIOIRI, T et al.Tetrahedron letters. 1984, Vol 25, Num 46, pp 5303-5306, issn 0040-4039Article

Constituents of Couepia paraensisSANDUJA, R; ALAM, M; EULER, K. L et al.Journal of natural products (Print). 1983, Vol 46, Num 1, issn 0163-3864, 149Article

Plasma membrane lipid structural order in doxorubicin-sensitive and -resistant P388 cells = Ordre structural des lipides membranaires dans les cellules P388 sensibles et résistantes à la doxorubicineRAMU, A; GLAUBIGER, D; MAGRATH, I. T et al.Cancer research (Baltimore). 1983, Vol 43, Num 11, pp 5533-5537, issn 0008-5472Article

Conversion of 2-β-D-ribofuranosylselenazole-4-carboxamide to an analogue of NAD with potent IMP dehydrogenase-inhibitory properties = Conversion du 2-bêta-D-ribofuranosylsélénazole-4-carboxamide en un analogue du NAD possédant des propriétés inhibitrices de l'IMP déshydrogénase importanesJAYARAM, H. N; AHLUWALIA, G. S; DION, R. L et al.Biochemical pharmacology. 1983, Vol 32, Num 17, pp 2633-2636, issn 0006-2952Article

ANTITUMOR AGENTS. LVI: THE PROTEIN SYNTHESIS INHIBITION BY GENKWADAPHNIN AND YUANHUACINE OF P-388 LYMPHOCYTIC LEUKEMIA CELLSLIOU YF; HALL IH; LEE KH et al.1982; JOURNAL OF PHARMACEUTICAL SCIENCES; ISSN 0022-3549; USA; DA. 1982; VOL. 71; NO 12; PP. 1340-1344; BIBL. 12 REF.Article

Anthracycline resistance in P388 murine leukemia and its circumvention by calcium antagonistsKESSEL, D; WILBERDING, C.Cancer research (Baltimore). 1985, Vol 45, Num 4, pp 1687-1691, issn 0008-5472Article

QSAR approach to understand the antitumour activity of organotinsBARBIERI, R.Inorganica chimica acta. 1992, Vol 191, Num 2, pp 253-259, issn 0020-1693Article

Gamma interferon administration differently affects sensitive or doxorubicin resistant P388 leukemia cells; a relationship with antioxidant defenses?ARMATA, M. G; CRESCIMANNO, M; TAPIERO, H et al.Pharmacological research. 1989, Vol 21, pp 21-22, issn 1043-6618, suppl. 1Conference Paper

Potentiation of the chemotherapeutic action of 5'-deoxy-5-fluorouridine in combination with guanosine and related compoundsIIGO, M; MIWA, M; ISHITSUKA, H et al.Cancer chemotherapy and pharmacology. 1987, Vol 19, Num 1, pp 61-64, issn 0344-5704Article

Mechanism of decrease of protein synthesis by sodium cyanate in murine P388 leukemia cellsLAZARUS, P; PANASCI, L. C.Cancer research (Baltimore). 1987, Vol 47, Num 19, pp 5102-5107, issn 0008-5472Article

Characterization of cellular lipids in doxorubicin-sensitive and -resistant P388 mouse leukemia cellsHOLLERAN, W. M; DEGREGORIO, M. W; RAM GANAPATHI et al.Cancer chemotherapy and pharmacology. 1986, Vol 17, Num 1, pp 11-15, issn 0344-5704Article

Effect of vitamin E on toxicity and antitumor activity of adriamycin in miceTANIGAWA, N; KATOH, H; KAN, N et al.Japanese journal of cancer research. 1986, Vol 77, Num 12, pp 1249-1255, issn 0910-5050Article

Intracellular glutathione as a determinant of responsiveness to antitumor drugsROMINE, M. T; KESSEL, D.Biochemical pharmacology. 1986, Vol 35, Num 19, pp 3323-3326, issn 0006-2952Article

Effects of p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt on leukemic infiltration of brain and liver in mice bearing P388 leukemia = Effets du sel potassique de l'acide p-(3,3-diméthyl-1-triazéno) benzoïque sur l'infiltration leucémique du cerveau et du foie chez les souris portant une leucémie P388SAVA, G; GIRALDI, T; BARTOLI-KLUGMANN, F et al.European journal of cancer & clinical oncology. 1984, Vol 20, Num 2, pp 287-289, issn 0277-5379Article

Chemical properties and biological effects of 2-haloethyl sulfonatesBOWDON, B. J; WHEELER, G. P; ADAMSON, D. J et al.Biochemical pharmacology. 1984, Vol 33, Num 19, pp 2951-2956, issn 0006-2952Article

Reversal of acquired resistance to doxorubicin in P388 murine leukemia cells by tamoxifen and other triparanol analoguesRAMU, A; GLAUBIGER, D; FUKS, Z et al.Cancer research (Baltimore). 1984, Vol 44, Num 10, pp 4392-4395, issn 0008-5472Article

Studies on antitumor cyclic hexapeptides RA obtained from Rubiae radix, Rubiaceae. III. On derivatives of RA-V and their in vivo activitiesITOKAWA, H; TAKEYA, K; MORI, N et al.Chemical and pharmaceutical bulletin. 1984, Vol 32, Num 8, pp 3216-3226, issn 0009-2363Article

Synthesis of cyclo-N-methyl-L-tyr-N-methyl-L-tyr-D-ala-L-ala-O,N-dimethyl-L-tyr-L-ala, a cyclic hexapeptide related to the antitumor agent deoxybouvardinBATES, R. B; GIN, S. L; HASSEN, M. A et al.Heterocycles (Sendai). 1984, Vol 22, Num 4, pp 785-790, issn 0385-5414Article

Restoration of drug sensitivity by nitroxazepine hydrochloride in P388 murine leukemia cells resistant to adriamycinCHITNIS, M. P; PRADHAN, S. G; STAYAMOORTHY, K et al.Cancer drug delivery. 1987, Vol 4, Num 1, pp 1-9, issn 0732-9482Article